Systemic treatment of prostate cancer [[electronic resource] /] / edited by Alan Horwich
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Systemic treatment of prostate cancer [[electronic resource] /] / edited by Alan Horwich
|
| Pubblicazione: | Oxford ; ; New York, : Oxford University Press, 2010 |
| Descrizione fisica: | 1 online resource (102 p.) |
| Disciplina: | 616.9946306 |
| Soggetto topico: | Prostate - Cancer - Diagnosis |
| Prostate - Cancer - Treatment | |
| Soggetto genere / forma: | Electronic books. |
| Altri autori: |
HorwichAlan
|
| Note generali: | Description based upon print version of record. |
| Nota di bibliografia: | Includes bibliographical references and index. |
| Nota di contenuto: | Contents; Preface; Symbols and abbreviations; Contributors; 1 Biological principles of hormone therapy; 2 PSA as a marker of progression and response in advanced prostate cancer; 3 Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer; 4 Systemic treatment of recurrence after local therapies; 5 First-line hormone therapy for metastatic prostate cancer; 6 Second- and third-line hormone therapies; 7 Chemotherapy for metastatic prostate cancer; 8 The role of bisphosphonates in the systemic treatment of prostate cancer; 9 Systemic isotope therapy of bone metastasis |
| 10 Biological targets and new drug development for prostate cancerIndex; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Z | |
| Sommario/riassunto: | Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r |
| Titolo autorizzato: | Systemic treatment of prostate cancer |
| ISBN: | 0-19-174025-X |
| 0-19-960737-0 | |
| 1-283-34833-0 | |
| 9786613348333 | |
| 0-19-157581-X | |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910457692103321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |
Serie:
Oxford oncology library.